HOME > 清水孝雄業績集 > 招待講演

招待講演

69. Lipidomics and phospholipid metabolism. 4th International Singapore Lipid Symposium, National University of Singapore, Singapore, Mar. 14-16, 2012.

68. Biochemistry and biology of LPA4, a non-Edg receptor. FASEB Summer Research Conference, Lucca, Italy, Aug. 14-19, 2011.

67. Lipid mediators in health and disease. The 1st Max Planck Society and University of Tokyo Joint Symposium, Frankfurt, Germany, May 17-19, 2011.

66. Turnover of glycerophospholipids by deacylation-reacylation cycle. (Organizer & Speaker), Keystone Symposia, Kyoto, Japan, Jun. 6-10, 2010.

65. Phospholipid and diseases. The 7th Joint Conference of Seoul National University and University of Tokyo 2010, Korea, Samsung Cancer Research Institute, Seoul Korea, May 28-Jun. 2, 2010.

64. New challenge for lipid mediators and phospholipid metabolism. (Invited Seminar), Weill College Medical of Cornell University, New York, NY, May 11-13, 2010.

63. Lipid mediators and lipid metabolism. (Invited Lecture), Taipei Medical University, Taipei Taiwan, Nov. 27, 2009.

62. Lipid mediators in health and disease. (Invited Lecture), National Health Research Institutes, Zhunan Taiwan, Oct. 2, 2009.

61. Lipid mediators and glycerophospholipid metabolism. The 50th International Conference on the Bioactive Lipid, Regensburg, Germany, Sep. 3, 2009.

60. Production of lipid mediators during Lands' cycle. (Organizer & Speaker), FASEB Summer Research Conference, USA, Carefree Resort and Villas, FASEB Summer Research Conference, USA, Carefree, AZ Jun. 29-Jul. 4., 2009.

59. Studies on lipid mediators and lipid metabolism. (Prize), Japan Academy Prize, Japan Academy, Tokyo, Japan, Jun.1, 2009.

58. Phospholipid metabolism: phospholipases and acyltransferases. (Keynote Speaker), Keystone Symposia, Olympic Valley, CA, Apr. 22-27, 2009.

57. Lipid mediators and phospholipid metabolism. Distinguished Lecture in Immunology Seminar, Cincinnati Children’s Hospital Center, Cincinnati, OH, USA, Oct. 20, 2008.

56. Lysophosphatidylcholine acyltranceferase 1 and 2. (Co-Organizer & Speaker), FASEB Summer Research Conference, New Haven, CT, Jul. 24-29, 2008.

55. Biochemical and pathophysiological roles of two types of leukotoriene B4 receptors (BLT1 and BLT2). Keystone Symposia, Big Sky Resort, MT, Jan. 9-15, 2008.

54. Phospholipase A2 and lysophospholipid acyltransferases (Lands' cycle). The 10th International Conference on Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Related Diseases, Montreal, Canada, Sep. 19-24, 2007.

53. Pathway-oriented profiling of lipid mediators. (Keynote Speaker), FASEB Summer Research Conference on Lysophospholipid Mediators, USA, Tuscon, AZ, Jun. 9-14, 2007.

52. Lipid mediators and phospholipid metabolism. (Keynote Speaker), FASEB Summer Research Conference, Tucson, AZ, Jun. 9-14, 2007.

51. Cloning and characterization of acetyl-CoA: lysoPAF acetyltransferase genes. The 3rd International Conference on Phospholipase A2 & Lipid Mediator, Sorrento, Italy, May 10, 2007.

50. Profiling lipid mediators and membrane lipids in various diseases models. Keystone Symposia, Sagebrush Inn & Conference Center, Taos, NM, Feb. 21-23, 2007.

49. Phospholipase A2 and lipid mediators. National Jewish Health, University of Colorado, Denver, CO, Feb. 19, 2007.

48. Lipid mediators; fundamental regulators of immune responses and inflammatory reactions. RCAI-JST, International Symposium on Immunology, Yokohama, Japan, Jun. 16-18, 2006.

47. The eicosanoid cascade: Lipid mediators of chronic inflammation. Days of Molecular Medicine 2006, Stockholm, Sweden, May 24-27, 2006.

46. Biochemistry and biology of leukotriene B4 receptors. Keystone Symposia on Eicosanoido in Inoflammation and Chironic Diseases, Snowbird, UT, Jan. 10-15, 2006.

45. Cytosolic phospholipase A2: biological significance and molecular diversity. (Plenary lecture), The 9th International Conference on Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Related Diseases, San Francisco, CA, Sep. 11-14, 2005.

44. Lipid mediators in health and diseases. Pharmacology Seminar, University of California San Diego, La Jolla, CA, Sep. 9, 2005.

43. Lysophopholipid/proton sensing receptors. FASEB Summer Research Conference on Lysophospholid Mediators in Health and Diseases., Snowmass, CO, Jun. 11-16, 2005.

42. Roles of cytosolic phospholipase A2 in vitro and in vivo. (Plenary lecture), 2nd International Conference on Phospholipase A2/8th International PAF Conference (Joint meeting), Berlin, Germany, Oct. 6-10, 2004.

41. Pysiological roles of cPLA2 enzymes. FASEB Summer Research Conference on Phospholipases, Pine Mountains, GA, Jul. 17-24, 2004.

40. Lipid mediators: from bench to clinic. Ernst Schering Foundation Symposium by Former Winners, Berlin, Germany, Jul. 21-23, 2003.

39. Lipid signaling molecules in health and diseases. Chancellor’s Award Lecture of Louisiana State University, New Orleans, LA, May 19, 2003.

38. Metabolism and receptors for leukotrienes and lipid mediators. (Co-organizer), Keystone Symposia on Eicosanoids Lipid Mediators, Tahoe, CA, Mar. 11-17, 2003.

37. Cytosolic phospholipase A2 and related molecules. 12th International Conference on Advances in Prostaglandin, Leukotriene and Other Bioactive Lipid Research, Istanbul, Turkey, Aug. 25-29, 2002.

36. Roles of cytosolic phospholipase A2. International Symposium on Recent Biomedical Advances on Eicosanoid Research, Berlin, Germany, Aug. 22-24, 2002.

35. Roles of cytosolic phospholipase A2 and related molecules in vivo. FASEB Summer Research Conference on Phospholipases, Tuscon, AZ, Jun. 28-Jul. 3, 2002.

34. Advance in eicosanoid research. 10th Anniversary of Ernst Schering Research Foundation Workshop, Berlin, Germany, Nov. 23-24, 2001.

33. Roles of cytosolic phospholipase A2 in vivo. (Plenary lecture), The 7th International Conference on Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Related Diseases, USA, Vanderbilt, Nashville, TN, Oct. 14-17, 2001.

32. Cytosolic phospholipase A2 and related molecules in the brain. The 7th International Congress on Platelet-Activating Factor and Lipid Mediators, Tokyo, Japan, Sep. 24-27, 2001.

31. Roles of cytosolic phospholipase A2 and related molecules in vivo. FASEB Summer Research Conference on Phospholipases, Snowmass Village, CO, Jul. 8-13, 2000.

30. Leukotriene B4 receptors: from clone to clinic. The 11th International Conference on Prostaglandin and Leukotriene Research, Florence, Italy, Jun. 4-8, 2000.

29. Role of cytosolic phospholipase A2 in vitro and in vivo. The 6th International Conference on Eicosanoid and Other Bioactive Lipids in Cancer, Inflammation and Related Diseases, Boston, MA, Sep. 12-15, 1999.

28. Leukotriene receptor and signal transduction. Ernst Shering Research Foundation Workshop: Advances in Eicosanoid Research, San Francisco, CA, Jun. 28-30, 1999.

27. Role of cytosolic phospholipase A2 in vivo. 1st International Conference on Phospholipase A2, Berlin, Germany, May 26-29, 1999.

26. A Keynote Address: Biosynthesis and functions of lipid mediators. (Plenary lecture), Keystone Symposia Keystone, CO, Apr. 1-7, 1999.

25. Cloning and characterization of leukotriene B4 receptor. Leukotrienes as Targets of Asthma and Other Diseases: Current Basic and Clinical Research, Sweden, Stockholm, Nov. 15-17, 1998.

24. Lipid mediators; from clone to clinic. (Plenary lecture), The 33rd Annual Southeastern Regional Lipid Conference, Cashiers, NC, Nov. 4-6, 1998.

23. Cloning of leukotriene B4 receptors from HL-60 cells. Gordon Research Conference: Biochemistry of Lipids and Lipid Mediators, Kimball Union Academy, Meriden, NH, Jun. 22-27, 1997.

22. Tissue-specific expression of platelet-activating factor receptor gene by different promoter usage. FASEB Conference, New Orleans, LA, Jun. 1-6, 1996.

21. Lipid messengers in synaptic transmission. 1st France-Japan Workshop on Neurosciences, Paris, France, Nov. 20-21, 1995.

20. Genes and signal transduction of platelet activating factor receptor. 4th International Conference on Eicosanoid and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury, Hong-Kong, China, Oct. 4-7, 1995.

19. Regulation of PAF receptor gene. 2nd International Conference of Inflammation, Brighton, UK, Sep. 17-22, 1995.

18. PAF receptor-from clone to clinic. Fifth International Congress on Platelet-activating Factor and Related Lipid Mediators, Berlin, Germany, Sep. 12-16, 1995.

17. Genes, signal transduction and possible roles of PAF in hippocampal neuron and glia. (Speaker, and session chair), 15th Biennial Meeting of the International Society for Neurochemistry, Kyoto, Japan, Jul. 1-7, 1995.

16. Activation of MAP kinase and arachidonate release by two G-protein-coupled receptor expressed in the rat hippocampus. (Speaker, and organizer), Satellite Meeting of 15th ISN "Lipid Messengers in the Nervous System", Tokyo, Japan, Jun. 28-30, 1995.

15. Structure and regulation of PAF receptor gene. 1995 Annual Meeting of American Society of Pharmacology and Experimental Therapeutics (ASPET), Atlanta, GA, Apr. 10-15, 1995.

14. MAP kinase activation by platelet-activating factor receptor/G-proteins. 12th International Congress of Pharmacology (IUPHAR), Montreal, Canada, Jul. 24-29, 1994.

13. Regulation and signal transduction of PAF receptor. The 9th International Conference on Prostaglandins and Related Compounds, Florence, Italy, Jun. 6-10, 1994.

12. PAF receptor and MAP kinase. Leon Wolfe Neurochemical Symposium, New Orleans, LA, May 9-13, 1994.

11. Molecular cloning and signal transduction of PAF receptor. International Symposium on Molecular Biology of Arachidonate Cascade, Kyoto, Japan, Dec. 6-7, 1993.

10. Biosynthesis and metabolism of leukotriene B4. International Symposium on Molecular Biology of Arachidonate Cascade, Kyoto, Japan, Dec. 6-7, 1993.

9. Platelet-activating factor receptor and signal transduction. The New York Academy of Science; Cellular Generation, Transport and Effects of Eicosanoids, Stockholm, Sweden, Nov. 14-17, 1993.

8. Structure and function of platelet-activating factor receptor. Ares-Serono Symposium, Heidelberg, Germany, Apr. 22-24, 1993.

7. Structure and function of platelet-activating factor receptor. The 4th International Congress on Platelet-activating Factor and Related Lipid Mediators, Salt Lake City, UT, Sep. 22-26, 1992.

6. Site-directed mutagenesis of leukotriene A4 hydrolase. The 8th International Conference on Prostaglandins and Related Compounds, Montreal, Canada, Jul. 26-31, 1992.

5. Platelet-activating factor in the brain. The 8th International Conference on Prostaglandins and Related Compounds, Montreal, Canada, Jul. 26-31, 1992.

4. Arachidonic acid cascade. Japanese-German Workshop on Cancer, Essen, Germany, Oct. 24-26, 1991.

3. Platelet-activating factor receptor and signal transduction. The 3rd International Conference of Eicosanoids and Other Bioactive Lipids, Berlin, Germany, Sep. 21-24, 1991.

2. Biosynthesis of leukotriene C4. The First Biennial International Conference on Amino Acid Research; Frontiers and New Horizons, Kyoto, Japan, Aug. 14-18, 1991.

1. Molecular properties of platelet-activating factor receptor. FASEB Meeting, Atlanta, GA, Apr. 21-25, 1991.